| Bioactivity | AChE/BuChE-IN-4(compound 4a) is aorally activeandbrain-penetrantmultitarget-directedAChE/BuChEinhibitor againstAChEandBuChE, with theIC50of 2.08 and 7.41 μM[1]. |
| Target | 2.08 and 7.41 μM( |
| Name | AChE/BuChE-IN-4 |
| CAS | 1997158-25-4 |
| Formula | C17H23N5 |
| Molar Mass | 297.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Conceição RAD, et al. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease [published online ahead of print, 2023 Oct 5]. J Cell Biochem. 2023;10.1002/jcb.30483. |
AChE/BuChE-IN-4
CAS: 1997158-25-4 F: C17H23N5 W: 297.40
AChE/BuChE-IN-4(compound 4a) is aorally activeandbrain-penetrantmultitarget-directedAChE/BuChEinhibitor againstAChEandBu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.